9,10-dimethyl-1,2-benzanthracene has been researched along with salicylates in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Rey, BM; Durán, HA | 1 |
Colby, AB; Reiners, JJ | 1 |
Logani, MK; Slaga, TJ; Solanki, V; Yotti, L | 1 |
de Rey, BM; Durán, HA; Lanfranchi, H; Palmieri, MA | 1 |
George, J; Kuttan, R | 1 |
Abbadessa, G; Dacasto, M; Di Carlo, F; Nebbia, C; Racca, S; Sartori, ML; Spaccamiglio, A | 1 |
6 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and salicylates
Article | Year |
---|---|
Differential oxidative stress induced by two different types of skin tumor promoters, benzoyl peroxide and 12-O-tetradecanoylphorbol-13-acetate.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoyl Peroxide; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Luminescent Measurements; Mice; Mice, Inbred Strains; Oxidation-Reduction; Salicylates; Skin; Tetradecanoylphorbol Acetate | 1991 |
Survey of cytotoxicities and antimutagenic and antitumor initiating activities of Cu(II)(3,5-diisopropylsalicylate)2 and its analogs in a keratinocyte-mediated mutation assay and the murine skin multistage carcinogenesis model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzo(a)pyrene; Cell Line; Cell Survival; Cells, Cultured; Copper; Copper Sulfate; Epidermal Cells; Epidermis; Mice; Mice, Inbred Strains; Mutation; Papilloma; Salicylates; Skin Neoplasms | 1988 |
The reduction of tumor initiating activity and cell mediated mutagenicity of dimethylbenz[a]anthracene by a copper coordination compound.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Biotransformation; Cocarcinogenesis; Cricetinae; Female; Mice; Salicylates; Skin Neoplasms | 1984 |
Inhibition of benzoyl peroxide-induced tumor promotion and progression by copper(II)(3,5-diisopropylsalicylate)2.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoyl Peroxide; Carcinoma, Squamous Cell; Cocarcinogenesis; Female; Incidence; Keratoacanthoma; Mice; Papilloma; Salicylates; Skin Neoplasms | 1993 |
Mutagenic, carcinogenic and cocarcinogenic activity of cashewnut shell liquid.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Anacardic Acids; Animals; Carcinogenicity Tests; Carcinogens; Cocarcinogenesis; Female; Mice; Mutagenicity Tests; Neoplasms, Experimental; Plant Extracts; Plants, Toxic; Resorcinols; Salicylates; Salmonella typhimurium; Skin Neoplasms | 1997 |
The aspirin metabolite, salicylate, inhibits 7,12-dimethylbenz[a]anthracene-DNA adduct formation in breast cancer cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP1A1; DNA Adducts; Female; Humans; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Salicylates | 2006 |